Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios D Anastasilakis

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Thyroid : Official Journal of the American Thyroid Association|October 2, 2010
Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysisKonstantinos A Toulis, Athanasios D Anastasilakis, Thrasivoulos G Tzellos, et al.
Metabolism: Clinical and Experimental|September 14, 2016
Activin A and follistatin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Medical Hypotheses|April 13, 2011
Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesisAthanasios D Anastasilakis, Stergios A Polyzos, Chrysostomos D Anastasilakis, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implicationsIlias D Vachliotis, Athanasios D Anastasilakis, Antonis Goulas, et al.
Bone Reports|February 20, 2026
Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Pituitary|February 1, 2011
Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosisAthanasios D Anastasilakis, Gregory A Kaltsas, Georgios Delimpasis, et al.
Hormones (Athens, Greece)|April 17, 2020
Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyPolyzois Makras, Maria P Yavropoulou, Evanthia Kassi, et al.
Therapeutics and Clinical Risk Management|July 7, 2012
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumabAthanasios D Anastasilakis, Konstantinos A Toulis, Stergios A Polyzos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2013
Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trialAthanasios D Anastasilakis, Stergios A Polyzos, Athina Gkiomisi, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Irisin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Thyroid : Official Journal of the American Thyroid Association|October 2, 2010
Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysisKonstantinos A Toulis, Athanasios D Anastasilakis, Thrasivoulos G Tzellos, et al.
Metabolism: Clinical and Experimental|September 14, 2016
Activin A and follistatin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Medical Hypotheses|April 13, 2011
Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesisAthanasios D Anastasilakis, Stergios A Polyzos, Chrysostomos D Anastasilakis, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implicationsIlias D Vachliotis, Athanasios D Anastasilakis, Antonis Goulas, et al.
Bone Reports|February 20, 2026
Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Pituitary|February 1, 2011
Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosisAthanasios D Anastasilakis, Gregory A Kaltsas, Georgios Delimpasis, et al.
Hormones (Athens, Greece)|April 17, 2020
Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyPolyzois Makras, Maria P Yavropoulou, Evanthia Kassi, et al.
Therapeutics and Clinical Risk Management|July 7, 2012
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumabAthanasios D Anastasilakis, Konstantinos A Toulis, Stergios A Polyzos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2013
Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trialAthanasios D Anastasilakis, Stergios A Polyzos, Athina Gkiomisi, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Irisin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Pageof 16